Advanced Cancer
Showing NaN - NaN of 28
Advanced Cancer, Anal Carcinoma, Anal Cancer Trial in Worldwide (pembrolizumab)
Recruiting
- Advanced Cancer
- +24 more
- pembrolizumab
-
Los Angeles, California
- +21 more
Jan 18, 2023
Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)
Recruiting
- Metastatic Cancer
- +2 more
- ASP9801
- Pembrolizumab
-
Birmingham, Alabama
- +26 more
Jan 6, 2023
Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (GZ17-6.02, Capecitabine)
Active, not recruiting
- Advanced Cancer
- +16 more
-
Scottsdale, Arizona
- +3 more
Dec 22, 2022
Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Worldwide (Ramucirumab, Merestinib, Cisplatin)
Active, not recruiting
- Biliary Tract Cancer
- +2 more
- Ramucirumab
- +5 more
-
Tucson, Arizona
- +91 more
Oct 18, 2022
Advanced Cancer, Angiosarcoma, Colorectal Cancer Without Liver Metastases Trial in United States (Botensilimab, Balstilimab)
Recruiting
- Advanced Cancer
- +7 more
-
Scottsdale, Arizona
- +14 more
Sep 15, 2022
Advanced Cancer, End Stage Organ Failure Trial in United States (Nurse-led telephonic case management, Facilitated,outpatient
Active, not recruiting
- Advanced Cancer
- End Stage Organ Failure
- Nurse-led telephonic case management
- Facilitated,outpatient specialty palliative care
-
Los Angeles, California
- +17 more
Aug 16, 2022
Advanced Cancer Trial in Worldwide (BMS-986258, Nivolumab, rHuPH20)
Active, not recruiting
- Advanced Cancer
- BMS-986258
- +2 more
-
Los Angeles, California
- +15 more
Feb 11, 2022
Advanced Cancer, Ovarian Cancer, Breast Cancer Trial in United States (COM701, COM701 with Opdivo (Nivolumab).)
Recruiting
- Advanced Cancer
- +9 more
- COM701
- COM701 with Opdivo (Nivolumab).
-
Los Angeles, California
- +10 more
Jan 25, 2022
Advance Care Planning, Advance Directives, Advanced Cancer Trial in Irvine, Los Angeles, San Francisco (Advance directive,
Active, not recruiting
- Advance Care Planning
- +2 more
- Advance directive
- +2 more
-
Irvine, California
- +2 more
Sep 29, 2021
Advanced Cancer Trial in United States (Mocetinostat - 50 mg, Mocetinostat - 70 mg, Mocetinostat - 90 mg)
Terminated
- Advanced Cancer
- Mocetinostat - 50 mg
- +4 more
-
Mobile, Alabama
- +14 more
Mar 10, 2021
Advanced Cancer, Advanced Malignancies Trial in Australia, Spain, United States (Cemiplimab, Hypofractionated radiotherapy,
Completed
- Advanced Cancer
- Advanced Malignancies
- Cemiplimab
- +7 more
-
Gilbert, Arizona
- +46 more
Jan 23, 2020
Advanced Cancer Trial in Worldwide (PF-05212384, PD-0325901, irinotecan)
Advanced Cancer, Metastatic Solid Tumors Trial in Los Angeles, San Francisco, Cleveland (NKTR-102)
Completed
- Advanced Cancer
- Metastatic Solid Tumors
-
Los Angeles, California
- +2 more
Dec 20, 2016